Condition
Glucosamine
Total Trials
2
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Glucosamine Liquid Without Liposomal
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Phase 4 (1)
Trial Status
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Glucosamine Liquid Without Liposomal1
- Lowemulsified Liposomal Glucosamine Liquid1
- Diacerein1
- Highemulsified Liposomal Glucosamine Liquid1
- Glucosamine Tablet Without Liposomal1
Active Sponsors
- TCI Co., Ltd.1
- Ramathibodi Hospital1
Top Investigators
Department of Orthopaedics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Mahidol University, Thailand.
TCI Co., Ltd.
Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand
Related Conditions
- Diacerein1
- Liposomal Encapsulation1
- Osteoarthritis1